谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition Through MTAP Loss.

Andrew Fedoriw,Satyajit R. Rajapurkar,Shane O'Brien,Sarah V. Gerhart,Lorna H. Mitchell,Nicholas D. Adams,Nathalie Rioux,Trupti Lingaraj,Scott A. Ribich,Melissa B. Pappalardi, Niyant Shah,Jenny Laraio,Yan Liu,Michael Butticello,Chris L. Carpenter,Caretha Creasy,Susan Korenchuk,Michael T. McCabe,Charles F. McHugh,Raman Nagarajan,Craig Wagner,Francesca Zappacosta,Roland Annan,Nestor O. Concha,Roberta A. Thomas,Timothy K. Hart,Jesse J. Smith,Robert A. Copeland,Mikel P. Moyer, John Campbell,Kim Stickland, James Mills, Suzanne Jacques-O'Hagan,Christina Allain,Danielle Johnston,Alejandra Raimondi,Margaret Porter Scott,Nigel Waters,Kerren Swinger,Ann Boriack-Sjodin,Tom Riera,Gideon Shapiro,Richard Chesworth,Rabinder K. Prinjha,Ryan G. Kruger,Olena Barbash,Helai P. Mohammad

Cancer Cell（2019）

引用 179|浏览82
暂无评分
关键词
cancer biology,splicing,biomarker,arginine methylation,post translational modifications,Type I PRMT,PRMT5,MTAP
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要